Loading...

Viva Tai, RD, MPH

TitleSenior Dietitian - Supervisor
SchoolUCSF School of Medicine
DepartmentMedicine
Address1001 Potrero Ave
San Francisco CA 94110
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Gugliucci A, Lustig RH, Caccavello R, Erkin-Cakmak A, Noworolski SM, Tai V, Wen MJ, Mulligan K, Schwarz JM. Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome. Atherosclerosis. 2016 Oct; 253:171-177. PMID: 27451002.
      View in: PubMed
    2. Lustig RH, Mulligan K, Noworolski SM, Tai V, Wen MJ, Erkin-Cakmak A, Gugliucci A, Schwarz JM. Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome. Obesity (Silver Spring). 2016 Feb; 24(2):453-60. PMID: 26499447.
      View in: PubMed
    3. Schwarz JM, Noworolski SM, Wen MJ, Dyachenko A, Prior JL, Weinberg ME, Herraiz LA, Tai V, Bergeron N, Bersot TP, Rao MN, Schambelan M, Mulligan K. Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat. J Clin Endocrinol Metab. 2015 Jun; 100(6):2434-42. PMID: 25825943; PMCID: PMC4454806 [Available on 06/01/16].
      View in: PubMed, PubMed Central
    4. Rao MN, Schambelan M, Tai V, Abrams DI, Khatami H, Havel PJ, Sakkas G, Mulligan K. Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected Men. AIDS Res Treat. 2012; 2012:103072. PMID: 22966425; PMCID: PMC3433112.
      View in: PubMed, PubMed Central
    5. Wilson JP, Mulligan K, Fan B, Sherman JL, Murphy EJ, Tai V, Powers CL, Marquez L, Ruiz-Barros V, Shepherd JA. Dual-energy X-ray absorptiometry-based body volume measurement for 4-compartment body composition. Am J Clin Nutr. 2012 Jan; 95(1):25-31. PMID: 22134952; PMCID: PMC3238462.
      View in: PubMed, PubMed Central
    6. Rao MN, Mulligan K, Tai V, Wen MJ, Dyachenko A, Weinberg M, Li X, Lang T, Grunfeld C, Schwarz JM, Schambelan M. Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance. J Clin Endocrinol Metab. 2010 Sep; 95(9):4361-6. PMID: 20610601; PMCID: PMC2936071.
      View in: PubMed, PubMed Central
    7. Mulligan K, Khatami H, Schwarz JM, Sakkas GK, DePaoli AM, Tai V, Wen MJ, Lee GA, Grunfeld C, Schambelan M. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. J Clin Endocrinol Metab. 2009 Apr; 94(4):1137-44. PMID: 19174500; PMCID: PMC2682465.
      View in: PubMed, PubMed Central
    8. Tai V, Schambelan M, Algren H, Shayevich C, Mulligan K. Effects of recombinant human growth hormone on fat distribution in patients with human immunodeficiency virus-associated wasting. Clin Infect Dis. 2002 Nov 15; 35(10):1258-62. PMID: 12410487.
      View in: PubMed
    9. Mulligan K, Tai V, Algren H, Abrams DI, Leiser RJ, Lo JC, Schambelan M. Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy. J Acquir Immune Defic Syndr. 2001 Apr 15; 26(5):443-8. PMID: 11391163.
      View in: PubMed
    10. Mulligan K, Grunfeld C, Tai V, Algren H, Pang M, Chernoff DN, Lo JC, Schambelan M. Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndr. 2000 Jan 1; 23(1):35-43. PMID: 10708054.
      View in: PubMed
    11. Mulligan K, Tai V, Schambelan M. Use of growth hormone and other anabolic agents in AIDS wasting. JPEN J Parenter Enteral Nutr. 1999 Nov-Dec; 23(6 Suppl):S202-9. PMID: 10571456.
      View in: PubMed
    12. Lo JC, Mulligan K, Tai V, Algren H, Schambelan M. Body shape changes in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Nov 1; 19(3):307-8. PMID: 9803975.
      View in: PubMed
    13. Johansen KL, Mulligan K, Tai V, Schambelan M. Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol. 1998 Jun; 9(6):1080-4. PMID: 9621292.
      View in: PubMed
    14. Mulligan K, Tai V, Schambelan M. Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting--a clinical research center study. J Clin Endocrinol Metab. 1998 May; 83(5):1542-7. PMID: 9589652.
      View in: PubMed
    15. Lo JC, Mulligan K, Tai V, Algren H, Schambelan M. "Buffalo hump" in men with HIV-1 infection. Lancet. 1998 Mar 21; 351(9106):867-70. PMID: 9525364.
      View in: PubMed
    16. Mulligan K, Tai V, Schambelan M. Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 May 1; 15(1):43-8. PMID: 9215653.
      View in: PubMed
    17. Mulligan K, Tai V, Schambelan M. Energy expenditure in human immunodeficiency virus infection. N Engl J Med. 1997 Jan 2; 336(1):70-1. PMID: 8984340.
      View in: PubMed
    Viva's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (79) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (15) people
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    Back to TOP